V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330005684 | 330011498 | 1.81 | 75 | Curative (C) | 2014-06-28 | 2014-07-06 | Mitotane 2g | Y | N | 330024475 | BEP |
| 330005685 | 330011498 | null | 0 | Curative (C) | 2017-03-27 | 2017-04-17 | Carboplatin + Doxorubicin | N | N | 330024475 | FLUOROURACIL + MITOMYCIN + RT |
| 330005686 | 330011498 | 1.86 | 62.5 | Palliative (P) | 2015-09-16 | 2015-09-23 | VAC | 02 | N | 330024475 | CYCLOPHOSPHAMIDE |
| 330005689 | 330002701 | 1.76 | 57 | null | null | 2014-09-10 | CNS LGG 2004 03 vinc weekly+ carbo | N | N | 330024487 | PEMBROLIZUMAB |
| 330005691 | 330007478 | null | 13.4 | Adjuvant (A) | 2015-05-15 | 2015-06-08 | VIDE | N | N | 330024492 | ALL INTERIM GUIDELINES |
| 330005692 | 330002703 | 1.91 | 79.3 | Palliative (P) | 2017-04-19 | 2017-05-10 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 330024494 | BENDAMUSTINE |
| 330005693 | 330002703 | 1.82 | 70 | null | 2017-05-02 | 2017-05-02 | VAI (Ifos 3g/m2) | N | null | 330024494 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 330005694 | 330002703 | null | 69.1 | Disease modification (D) | null | 2014-11-22 | ECX | null | null | 330024494 | CETUXIMAB + CISPLATIN + FU |
| 330005695 | 330002703 | 1.57 | 44.1 | Curative (C) | 2016-05-05 | 2016-05-05 | CNS LGG 2004 03 vinc weekly+ carbo | N | null | 330024494 | AML18 TRIAL |
| 330005696 | 330002704 | 1.51 | null | Curative (C) | 2017-07-10 | 2017-07-24 | Ipilimumab | null | N | 330024504 | ICE-R |
| 330005697 | 330002704 | null | 77.2 | Curative (C) | 2013-07-28 | 2013-08-04 | Cisplatin + Vinorelbine (IV) | N | N | 330024504 | CHLORAMBUCIL |
| 330005698 | 330002705 | 1.83 | 89.4 | Palliative (P) | 2014-11-06 | 2014-11-06 | INTERAACT trial | N | N | 330024514 | CAPECITABINE + CARBOPLATIN |
| 330005699 | 330002705 | 1.52 | 0 | Palliative (P) | 2013-11-05 | 2013-11-09 | CNS Low Grade Glioma Vinblastine | 2 | N | 330024514 | AML19 TRIAL |
| 330005700 | 330002706 | 1.63 | 61.3 | Adjuvant (A) | null | 2017-01-27 | Doxorubicin + Olaratumab | null | null | 330024517 | CHLORAMBUCIL |
| 330005701 | 330002707 | 1.72 | 65 | Palliative (P) | 2013-05-13 | 2013-05-13 | CARBOPLATIN + RT | 02 | N | 330024519 | CETUXIMAB + CISPLATIN + FU |
| 330005702 | 330002707 | 1.74 | 85.7 | Curative (C) | null | 2014-04-20 | ALL UKALL60+ TRIAL | null | null | 330024519 | HYDROXYCARBAMIDE |
| 330005703 | 330002707 | null | 58 | Curative (C) | 2013-05-29 | 2013-05-29 | Methotrexate + Folinic acid | 2 | N | 330024519 | DACARBAZINE |
| 330005704 | 330002708 | 1.77 | 76 | Curative (C) | 2013-02-26 | 2013-03-14 | Cisplatin + Pemetrexed | N | N | 330024532 | TOPOTECAN |
| 330005705 | 330002709 | 0 | 79.2 | Curative (C) | 2014-12-28 | 2014-12-28 | PEMBROLIZUMAB | 2 | N | 330024539 | CARBOPLATIN + DOXORUBICIN |
| 330005706 | 330002710 | 1.58 | 61 | Palliative (P) | 2014-04-18 | 2014-04-18 | Methotrexate + Folinic acid | 02 | N | 330024541 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 330005707 | 330007483 | 1.82 | 50 | Curative (C) | 2014-12-02 | 2014-12-02 | Cisplatin + Fluorouracil + RT 5day | 02 | N | 330024550 | POMB/ACE |
| 330005708 | 330002711 | 1.6 | 85.7 | Neo-adjuvant (N) | 2015-05-11 | 2015-05-25 | PEMBROLIZUMAB | N | N | 330024551 | IDARUBICIN |
| 330005709 | 330002712 | 1.78 | 84.9 | null | 2015-06-27 | 2015-07-01 | Fludarabine + Melphalan RIC Allo | N | N | 330024564 | BENDAMUSTINE |
| 330005710 | 330007484 | 1.78 | null | Curative (C) | 2017-05-24 | 2017-05-24 | EDP + MITOTANE | N | null | 330024565 | MITOTANE |
| 330005711 | 330002713 | 1.7 | 50 | Curative (C) | 2014-10-12 | 2014-10-30 | VINCRISTINE | N | N | 330024566 | BEVACIZUMAB |
| 330005712 | 330002713 | 1.6 | 61 | Curative (C) | 2017-12-11 | 2017-12-12 | Ipilimumab | N | N | 330024566 | HYDROXYCARBAMIDE |
| 330005713 | 330010069 | 1.62 | 72.6 | null | null | 2015-08-17 | CYCLOPHOSPHAMIDE + FLUDARABINE | null | null | 330024573 | BEP |
| 330005714 | 330010069 | 1.73 | 14.3 | Curative (C) | 2017-11-25 | 2018-01-02 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | null | N | 330024573 | MITOTANE |
| 330005715 | 330010069 | 1.7 | 0 | Neo-adjuvant (N) | 2013-09-21 | 2013-10-09 | Vinblastine weekly | N | Y | 330024573 | BCG |
| 330005716 | 330010069 | null | null | Disease modification (D) | 2016-10-29 | 2016-10-30 | CHOP R - 14 days | N | null | 330024573 | FLAG + IDARUBICIN |
| 330005717 | 330010069 | 1.6 | 35 | Palliative (P) | 2017-08-30 | 2017-08-30 | Cladribine (subcut) 5 days | 02 | N | 330024573 | IFOSFAMIDE |
| 330005718 | 330010069 | 1.64 | 73 | Neo-adjuvant (N) | 2016-03-09 | 2016-03-23 | Dacarbazine | N | N | 330024573 | METHOTREXATE INTRATHECAL |
| 330005719 | 330010069 | 1.57 | 61.3 | Curative (C) | 2016-08-21 | 2016-08-25 | Cyclophosphamide TBI Allograft | N | null | 330024573 | TCF |
| 330005720 | 330010069 | 1.86 | 83.5 | Adjuvant (A) | 2015-08-21 | 2015-08-27 | VAC | 2 | N | 330024573 | AZACITIDINE |
| 330005721 | 330010069 | null | 79.6 | null | null | 2013-08-16 | Vinblastine weekly | N | N | 330024573 | FLUDARABINE |
| 330005722 | 330013331 | 1.82 | 90 | Palliative (P) | 2013-12-18 | 2014-01-04 | AML 18 TRIAL | null | N | 330024605 | CISPLATIN + CYCLO + DOXORUBICIN |
| 330005723 | 330002714 | 1.7 | 61.5 | Palliative (P) | 2013-10-08 | 2013-10-09 | ABVD | N | N | 330024607 | CISPLATIN + VINORELBINE |
| 330005724 | 330002714 | 1.68 | 78.3 | Palliative (P) | 2014-05-21 | 2014-06-09 | MITOTANE | N | N | 330024607 | FLUOROURACIL + MITOMYCIN + RT |
| 330005725 | 330002715 | null | 61.3 | Curative (C) | 2015-01-15 | 2015-02-12 | ALL UKALL2011 Ind B Sht Dex (PAsp) | N | N | 330024611 | CYTARABINE |
| 330005726 | 330002716 | 1.78 | 100.2 | Palliative (P) | 2015-05-11 | 2015-05-12 | CAPECITABINE + CARBOPLATIN | N | N | 330024620 | AZACITIDINE |
| 330005727 | 330002717 | null | 53 | Palliative (P) | 2014-11-09 | 2014-12-01 | FLUOROURACIL + OXALIPLATIN | N | null | 330024621 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 330005728 | 330002718 | 1.76 | 94.9 | Neo-adjuvant (N) | 2016-03-06 | 2016-03-12 | ADE 10+3+5 | 02 | N | 330024625 | TOPOTECAN |
| 330005729 | 330002718 | 0 | 80.9 | Palliative (P) | 2015-12-01 | 2015-12-05 | TEMOZOLOMIDE | 2 | N | 330024625 | CISPLATIN + FLUOROURACIL + GEMCITABINE |
| 330005730 | 330002719 | 1.53 | 84.7 | Curative (C) | 2013-03-02 | 2013-03-06 | PEMBROLIZUMAB | N | N | 330024628 | CAV |
| 330005731 | 330002720 | 1.73 | null | Curative (C) | 2017-04-21 | 2017-05-01 | GC Int Guide Excranial GermCell JEB | N | N | 330024632 | CISPLATIN + DOCETAXEL |
| 330005732 | 330002721 | null | 69.9 | Palliative (P) | 2014-01-19 | 2014-02-01 | CAPECITABINE + CARBOPLATIN + Cetuximab | N | N | 330024634 | HYDROXYCARBAMIDE |
| 330005733 | 330002722 | 1.76 | 83.7 | Palliative (P) | 2017-03-22 | 2017-03-27 | IVE | 02 | Y | 330024637 | DOCETAXEL |
| 330005734 | 330002723 | 1.8 | 68.9 | Adjuvant (A) | 2013-04-24 | 2013-06-04 | Cladribine (subcut) 5 days | 02 | N | 330024642 | CARBOPLATIN + RT |
| 330005735 | 330007488 | 0 | 95.1 | Curative (C) | 2015-05-22 | 2015-05-22 | EpSSG NRSTS 2005 | N | N | 330024649 | VIDE |
| 330005736 | 330007488 | 1.75 | 75 | Palliative (P) | 2013-01-26 | 2013-02-12 | Hydroxycarbamide | N | N | 330024649 | CARBOPLATIN + DOCETAXEL |